Zoi Diamantopoulou, Ph.D.
My research interests primarily include Cancer Cell Biology and Molecular Oncology, in particular how different signal transduction pathways regulate tumor progression. Previously, I was a postdoctoral research fellow in the Cell Signaling Group of CRUK-Manchester Institute, UK, where I studied how Rac1 signaling regulates YAP/TAZ activity during colorectal cancer progression (Diamantopoulou et al., Cancer Cell, 2017; Whalley et al., Nature Communications, 2015; Woroniuk et al., Nature Communications, 2018). I was also a post-doctoral researcher in the CRRET, CNRS, University of Paris-Est, Paris/Immupharma PLC, FRANCE, where I investigated the mechanism of action of new anticancer multivalent pseudopeptides that were in phase I/IIa clinical trials (Diamantopoulou et al., Oncotarget, 2017). I earned my PhD from the University of Patras, Greece, where I studied how phosphatases regulate prostate cancer progression (Diamantopoulou et al., JBC, 2012; Diamantopoulou et al., Molecular Cancer, 2010; Bermek et al., Exp Cell Res, 2007).